These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17477425)

  • 1. Administration of dendritic cells modified by RNA interference prolongs cardiac allograft survival.
    Xiang J; Gu X; Zhou Y; Gong X; Qian S; Chen Z
    Microsurgery; 2007; 27(4):320-3. PubMed ID: 17477425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graded function of CD80 and CD86 in initiation of T-cell immune response and cardiac allograft survival.
    Xiang J; Gu X; Qian S; Chen Z
    Transpl Int; 2008 Feb; 21(2):163-8. PubMed ID: 17971032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of recipient-derived dendritic cells to induce donor-specific T-cell hyporesponsiveness.
    Tiao MM; Lu L; Tao R; Harnaha J; Fung JJ; Huang LT; Qian S
    Transplant Proc; 2004 Jun; 36(5):1592-4. PubMed ID: 15251391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-beta(1) gene modified immature dendritic cells exhibit enhanced tolerogenicity but induce allograft fibrosis in vivo.
    Sun W; Wang Q; Zhang L; Pan J; Zhang M; Lu G; Yao H; Wang J; Cao X
    J Mol Med (Berl); 2002 Aug; 80(8):514-23. PubMed ID: 12185452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival.
    Liang X; Lu L; Chen Z; Vickers T; Zhang H; Fung JJ; Qian S
    Transplantation; 2003 Aug; 76(4):721-9. PubMed ID: 12973117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection.
    Zhang X; Li M; Lian D; Zheng X; Zhang ZX; Ichim TE; Xia X; Huang X; Vladau C; Suzuki M; Garcia B; Jevnikar AM; Min WP
    Clin Immunol; 2008 Jun; 127(3):313-21. PubMed ID: 18358783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pretreatment of donor dendritic cells with NBD-peptide prolongs mouse cardiac allograft survival].
    Su G; Zhao WZ; Chen JJ; Xu J; Qiao CH; Liu C; Sun ZQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1562-7. PubMed ID: 18819868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic insights into achievement of cardiac allograft long-term survival by treatment with immature dendritic cells and sub-dose sirolimus.
    Tao R; Wang L; Chen CH; Wang SH; Demarco RA; Lotze MT; Thai NL; Fung JJ; Lu L; Qian S
    J Heart Lung Transplant; 2006 Mar; 25(3):310-9. PubMed ID: 16507425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells.
    Emmanouilidis N; Guo Z; Dong Y; Newton-West M; Adams AB; Lee ED; Wang J; Pearson TC; Larsen CP; Newell KA
    Transplantation; 2006 Feb; 81(3):455-62. PubMed ID: 16477234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival of limb allografts induced by pharmacologically conditioned, donor alloantigen-pulsed dendritic cells without maintenance immunosuppression.
    Ikeguchi R; Sacks JM; Unadkat JV; Solari M; Horibe EK; Thomson AW; Lee AW; Feili-Hariri M
    Transplantation; 2008 Jan; 85(2):237-46. PubMed ID: 18212629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolongation of cardiac allograft survival by systemic administration of immature recipient dendritic cells deficient in NF-kappaB activity.
    Tiao MM; Lu L; Tao R; Wang L; Fung JJ; Qian S
    Ann Surg; 2005 Mar; 241(3):497-505. PubMed ID: 15729074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.
    Lan YY; Tokita D; Wang Z; Wang HC; Zhan J; Brinkmann V; Thomson AW
    Transpl Immunol; 2008 Nov; 20(1-2):88-94. PubMed ID: 18694829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free bone graft attenuates acute rejection and in combination with cyclosporin a leads to indefinite cardiac allograft survival.
    Wang H; Ge W; Arp J; Zassoko R; Liu W; Ichim TE; Jiang J; Jevnikar AM; Garcia B
    J Immunol; 2009 May; 182(10):5970-81. PubMed ID: 19414748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promotion of long-term heart allograft survival by combination of mobilized donor plasmacytoid dendritic cells and anti-CD154 monoclonal antibody.
    Björck P; Coates PT; Wang Z; Duncan FJ; Thomson AW
    J Heart Lung Transplant; 2005 Aug; 24(8):1118-20. PubMed ID: 16102450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of donor-specific T-cell hyporesponsiveness using dexamethasone-treated dendritic cells in two fully mismatched rat kidney transplantation models.
    Stax AM; Gelderman KA; Schlagwein N; Essers MC; Kamerling SW; Woltman AM; van Kooten C
    Transplantation; 2008 Nov; 86(9):1275-82. PubMed ID: 19005410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of RNA interference on CD80 and CD86 expression in bone marrow-derived murine dendritic cells.
    Gu X; Xiang J; Yao Y; Chen Z
    Scand J Immunol; 2006 Dec; 64(6):588-94. PubMed ID: 17083614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of tolerogenic dendritic cells induced by interleukin-10 prolongs rat splenic allograft survival.
    Jiang H; Hou L; Qiao H; Pan S; Zhou B; Liu C; Sun X
    Transplant Proc; 2004 Dec; 36(10):3255-9. PubMed ID: 15686741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine bone marrow mesenchymal stem cells cause mature dendritic cells to promote T-cell tolerance.
    Wang Q; Sun B; Wang D; Ji Y; Kong Q; Wang G; Wang J; Zhao W; Jin L; Li H
    Scand J Immunol; 2008 Dec; 68(6):607-15. PubMed ID: 18959624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of immature dendritic cell injection before heterotropic cardiac allograft.
    Oh BC; Lee HM; Lim DP; Cho JJ; Lee G; Lee DS; Lee JR
    Transplant Proc; 2006 Dec; 38(10):3189-92. PubMed ID: 17175218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cells activated by lipopolysaccharide after dexamethasone treatment induce donor-specific allograft hyporesponsiveness.
    Emmer PM; van der Vlag J; Adema GJ; Hilbrands LB
    Transplantation; 2006 May; 81(10):1451-9. PubMed ID: 16732184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.